Greenwood Capital Associates’s CVS Health CVS Stock Holding History

Greenwood Capital Associates’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.42M	Buy	19,779 +71	+0.4%	+$5.47K	0.16%	127
2025 Q4	$1.56M	Buy	19,708 +834	+4%	+$65.7K	0.17%	118
2025 Q3	$1.42M	Sell	18,874 -61	-0.3%	-$4.18K	0.16%	118
2025 Q2	$1.31M	Buy	+18,935	New	+$1.24M	0.16%	118
2023 Q1	–	Sell	-49,363	Closed	-$4.6M	–	239
2022 Q4	$4.6M	Buy	49,363 +20,836	+73%	+$2.01M	0.75%	48
2022 Q3	$2.72M	Buy	28,527 +26,147	+1,099%	+$2.59M	0.47%	59
2022 Q2	$220K	Buy	2,380 +1,890	+386%	+$184K	0.04%	201
2022 Q1	$50K	Sell	490 -2,321	-83%	-$244K	0.01%	174
2021 Q4	$290K	Buy	+2,811	New	+$260K	0.04%	203
2019 Q1	–	Sell	-118,307	Closed	-$7.75M	–	182
2018 Q4	$7.75M	Buy	118,307 +61,480	+108%	+$4.59M	2.03%	10
2018 Q3	$4.47M	Buy	+56,827	New	+$4.06M	0.97%	41
2018 Q1	–	Sell	-25,972	Closed	-$1.88M	–	199
2017 Q4	$1.88M	Buy	+25,972	New	+$1.89M	0.44%	81

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Greenwood Capital Associates's CVS Position: Q1 2026 in Review

Greenwood Capital Associates increased its CVS Health (CVS) stake by 0.36% in Q1 2026, buying an estimated $5.47K and bringing the position to 19,779 shares worth $1.42M. The position accounts for 0.16% of the portfolio, ranked #127.

Greenwood Capital Associates first reported a position in CVS in Q4 2017 and has held it in 12 quarters since. The position peaked at $7.75M in Q4 2018. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Greenwood Capital Associates held 19,779 shares of CVS Health worth $1.42M as of Q1 2026.
Greenwood Capital Associates bought 71 CVS Health shares in Q1 2026, an estimated $5.47K.
CVS Health made up 0.16% of Greenwood Capital Associates's portfolio in Q1 2026, its #127 holding.
Greenwood Capital Associates first reported a position in CVS Health in Q4 2017 and has held it in 12 quarters since.
Greenwood Capital Associates's CVS Health position peaked at $7.75M in Q4 2018.
1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Greenwood Capital Associates's 13F filing for Q1 2026, filed 29 Apr 2026.